TheraCea has proudly secured the esteemed NSF National Innovation Corps (I-Corps) Award, a recognition that underscores our commitment to bridging the gap between laboratory innovation and real-world market implementation. I-Corps is dedicated to minimizing the risks inherent in technology translation, fostering experiential learning to accelerate the journey from research breakthroughs to practical applications. With an impressive track record, over 2,500 teams, including TheraCea, have engaged with I-Corps since its inception in 2012. Remarkably, nearly 1,400 of these teams have successfully launched startups, collectively raising an impressive $3.16 billion in subsequent funding. TheraCea's receipt of the NSF National I-Corps Award attests to our dedication to transformative innovation and our readiness to navigate the intricate pathway from laboratory discovery to substantial market impact.